Kyverna Therapeutics Unveils Strategic Priorities and Anticipated Milestones for 2025 at J.P. Morgan Healthcare Conference
Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic ...
Mena FN2d
Deadline Alert: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
On June 14, 2024, Kyverna provided an update on its lupus nephritis drug, KYV-101, and published an investor presentation disclosing adverse data regarding one of its clinical trials, despite ...
Yahoo Finance27d
Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
Jan. 6, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna ... its 2025 strategic priorities and key milestones during a presentation on Monday, January 13, 2025, at 5:15 p.m. PST.
Yahoo Finance20d
Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna ... its 2025 strategic priorities and key milestones during a presentation that will be made by Chief Executive Officer, Warner ...
Yahoo Finance19d
Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna ... announced it will present its 2025 strategic priorities and key milestones during a presentation that will be made by Chief ...